Amy F T Arnsten

Title: Amy F T Arnsten: Innovator in Neurodegeneration and Pharmacology

Introduction

Amy F T Arnsten is a prominent inventor based in Bethany, CT (US). She has made significant contributions to the fields of neurodegeneration and pharmacology. With a total of 2 patents, her work focuses on innovative methods to address critical health issues.

Latest Patents

Arnsten's latest patents include groundbreaking inventions aimed at preventing neurodegeneration of the association cortex in mammals. The first patent provides methods for reducing the risk of neurodegeneration and inhibiting the formation of phosphorylated tau or COXIV in the prefrontal cortex. This method involves administering a therapeutically effective amount of an α-adrenergic receptor agonist. The second patent introduces pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety. These compounds act as prodrugs, targeting specific regions in the body and providing pharmaceutical compositions for treating various infections and disorders.

Career Highlights

Arnsten is affiliated with Yale University, where she continues her research and development in pharmacological innovations. Her work has garnered attention for its potential impact on treating neurodegenerative diseases and other health conditions.

Collaborations

Some of her notable coworkers include Kenneth Shaw and Mingbao Zhang, who have contributed to her research endeavors.

Conclusion

Amy F T Arnsten stands out as an influential inventor in the realm of neurodegeneration and pharmacology. Her innovative patents reflect her commitment to advancing medical science and improving health outcomes.